PI3K/Akt: Getting it right matters

Oncogene

Volumn 27, Issue 50, 2008, Pages 6473-6488

  Franke, T F ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt interacting proteins; Akt PKB; Human disease; mTORC; PDK2; PI3K PTEN

Indexed keywords

CELL PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 2; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

BRAIN FUNCTION; CARCINOGENESIS; CELL CYCLE REGULATION; CELL FUNCTION; CELL SIZE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; EXPERIMENTAL MODEL; GENETIC MODEL; HUMAN; MENTAL DISEASE; METABOLIC DISORDER; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MENTAL DISORDERS; METABOLIC DISEASES; MODELS, ANIMAL; MODELS, GENETIC; NEOPLASMS; ONCOGENES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 54949109808     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.313     Document Type: Review

References (230)

1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P et al. (1996a). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551.
2. Alessi DR, Caudwell FB, Andjelkovic M, Hemmings BA, Cohen P. (1996b). Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett 399: 333-338.
3. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB et al. (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269.
4. Anai M, Shojima N, Katagiri H, Ogihara T, Sakoda H, Onishi Y et al. (2005). A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis. J Biol Chem 280: 18525-18535.
5. Aoki M, Batista O, Bellacosa A, Tsichlis P, Vogt PK. (1998). The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci USA 95: 14950-14955.
6. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R et al. (2003). Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63: 196-206.
7. Arnold SE, Talbot K, Hahn CG. (2005). Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 147: 319-345.
8. Ashcroft M, Ludwig RL, Woods DB, Copeland TD, Weber HO, MacRae EJ et al. (2002). Phosphorylation of HDM2 by Akt. Oncogene 21: 1955-1962.
9. Auger KR, Serunian LA, Soltoff SP, Libby P, Cantley LC. (1989). PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57: 167-175.
10. Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S et al. (2004). The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3: 772-775.
11. Bae SS, Cho H, Mu J, Birnbaum MJ. (2003). Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278: 49530-49536.
12. Balendran A, Casamayor A, Deak M, Paterson A, Gaffney P, Currie R et al. (1999). PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 9: 393-404.
13. Barthel A, Okino ST, Liao J, Nakatani K, Li J, Whitlock Jr JP et al. (1999). Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J Biol Chem 274: 20281-20286.
14. Barthwal MK, Sathyanarayana P, Kundu CN, Rana B, Pradeep A, Sharma C et al. (2003). Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J Biol Chem 278: 3897-3902.
15. Basso AD, Solit DB, Chiosis G, Giri B, Tsichlis P, Rosen N. (2002). Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J Biol Chem 277: 39858-39866.
16. Beaulieu JM, Gainetdinov RR, Caron MG. (2007). The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28: 166-172.
17. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. (2005). An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261-273.
18. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR et al. (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099-5104.
19. Bellacosa A, Franke TF, Gonzalez-Portal ME, Datta K, Taguchi T, Gardner J et al. (1993). Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene 8: 745-754.
20. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. (1991). A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254: 274-277.
21. Berra E, Diaz-Meco MT, Moscat J. (1998). The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273: 10792-10797.
22. Berwick DC, Dell GC, Welsh GI, Heesom KJ, Hers I, Fletcher LM et al. (2004). Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles. J Cell Sci 117: 5985-5993.
23. Berwick DC, Hers I, Heesom KJ, Moule SK, Tavare JM. (2002). The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J Biol Chem 277: 33895-33900.
24. Biondi RM, Cheung PC, Casamayor A, Deak M, Currie RA, Alessi DR. (2000). Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. EMBO J 19: 979-988.
25. Bleeker FE, Felicioni L, Buttitta F, Lamba S, Cardone L, Rodolfo M et al. (2008). AKT1(E17K) in human solid tumours. Oncogene, advance online publication, 26 May 2008; doi:10.1038/onc.2008.170.
26. Bozulic L, Surucu B, Hynx D, Hemmings BA. (2008). PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 30: 203-213.
27. Brazil DP, Hemmings BA. (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26: 657-664.
28. Brazil DP, Park J, Hemmings BA. (2002). PKB binding proteins. Getting in on the Akt. Cell 111: 293-303.
29. Brognard J, Sierecki E, Gao T, Newton AC. (2007). PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25: 917-931.
30. Brugge J, Hung MC, Mills GB. (2007). A new mutational AKTivation in the PI3K pathway. Cancer Cell 12: 104-107.
31. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
32. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. (2001). Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21: 952-965.
33. Burgering BMT, Coffer PJ. (1995). Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
34. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN et al. (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42: 318-321.
35. Calleja V, Alcor D, Laguerre M, Park J, Vojnovic B, Hemmings BA et al. (2007). Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol 5: e95.
36. Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS et al. (2004). Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64: 7678-7681.
37. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E et al. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321.
38. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. (2008). The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8: 187-198.
39. Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM et al. (2007). A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448: 439-444.
40. Carter AN, Huang R, Sorisky A, Downes CP, Rittenhouse SE. (1994). Phosphatidylinositol 3,4,5-trisphosphate is formed from phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets. Biochem J 301(Part 2): 415-420.
41. Cerezo A, Martinez AC, Lanzarot D, Fischer S, Franke TF, Rebollo A. (1998). Role of Akt and c-Jun N-terminal kinase 2 in apoptosis induced by interleukin-4 deprivation. Mol Biol Cell 9: 3107-3118.
42. Chan TO, Rittenhouse SE, Tsichlis PN. (1999). AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014.
43. Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. (2000). Molecular genetic advances in tuberous sclerosis. Hum Genet 107: 97-114.
44. Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandez MH et al. (2003). Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113: 457-468.
45. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15: 2203-2208.
46. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK et al. (1996). Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. PNAS 93: 3636-3641.
47. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw III EB et al. (2001a). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731.
48. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. (2001b). Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349-38352.
49. Coffer PJ, Woodgett JR. (1991). Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem 201: 475-481.
50. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
51. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG et al. (2004). Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279: 5405-5412.
52. Danial NN, Gramm CF, Scorrano L, Zhang CY, Krauss S, Ranger AM et al. (2003). BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424: 952-956.
53. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB et al. (2000). 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6: 41-51.
54. Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH. (1997). Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem 272: 17269-17275.
55. Dong B, Valencia CA, Liu R. (2007). Ca(2+)/calmodulin directly interacts with the pleckstrin homology domain of AKT1. J Biol Chem 282: 25131-25140.
56. Dong LQ, Liu F. (2005). PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am J Physiol Endocrinol Metab 289: E187-E196.
57. Downward J. (2003). Cell biology: metabolism meets death. Nature 424: 896-897.
58. Dragoi AM, Fu X, Ivanov S, Zhang P, Sheng L, Wu D et al. (2005). DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J 24: 779-789.
59. Du K, Herzig S, Kulkarni RN, Montminy M. (2003). TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300: 1574-1577.
60. Du K, Tsichlis PN. (2005). Regulation of the Akt kinase by interacting proteins. Oncogene 24: 7401-7409.
61. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM et al. (1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665.
62. Dummler B, Tschopp O, Hynx D, Yang ZZ, Dirnhofer S, Hemmings BA. (2006). Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol 26: 8042-8051.
63. Easton JB, Kurmasheva RT, Houghton PJ. (2006). IRS-1: auditing the effectiveness of mTOR inhibitors. Cancer Cell 9: 153-155.
64. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS et al. (2005). Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25: 1869-1878.
65. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36: 131-137.
66. Engelman JA, Luo J, Cantley LC. (2006). The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
67. Feng J, Park J, Cron P, Hess D, Hemmings BA. (2004). Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279: 41189-41196.
68. Figueroa C, Tarras S, Taylor J, Vojtek AB. (2003). Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. J Biol Chem 278: 47922-47927.
69. Franke TF. (2007). Akt-interacting proteins: attractive opposites. focus on 'Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways'. Am J Physiol Cell Physiol 293: C1768-C1770.
70. Franke TF. (2008). Intracellular signaling by Akt: bound to be specific. Sci Signal 1: pe29.
71. Franke TF, Cantley LC. (1997). Apoptosis. A Bad kinase makes good. Nature 390: 116-117.
72. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. (2003). PI3K/Akt and apoptosis: size matters. Oncogene 22: 8983-8998.
73. Franke TF, Kaplan DR, Cantley LC, Toker A. (1997). Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275: 665-668.
74. Franke TF, Tartof KD, Tsichlis PN. (1994). The SH2-like Akt homology (AH) domain of c-akt is present in multiple copies in the genome of vertebrate and invertebrate eucaryotes. Cloning and characterization of the Drosophila melanogaster c-akt homolog Dakt1. Oncogene 9: 141-148.
75. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK et al. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736.
76. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R et al. (2003). PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3: 117-130.
77. Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA et al. (2006). mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 16: 1865-1870.
78. Fritzius T, Moelling K. (2008). Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis. EMBO J 27: 1399-1410.
79. Fujita E, Jinbo A, Matuzaki H, Konishi H, Kikkawa U, Momoi T. (1999). Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem Biophys Res Commun 264: 550-555.
80. Gajewski TF, Thompson CB. (1996). Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87: 589-592.
81. Gao H, Yu Z, Bi D, Jiang L, Cui Y, Sun J et al. (2007). Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression. Mol Cell Biochem 305: 35-44.
82. Gao T, Furnari F, Newton AC. (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18: 13-24.
83. Garcia BG, Wei Y, Moron JA, Lin RZ, Javitch JA, Galli A. (2005). Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 68: 102-109.
84. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC et al. (2004). A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304: 1325-1328.
85. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. (2001). Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406-1418.
86. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G et al. (2007). Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
87. Guertin DA, Sabatini DM. (2007). Defining the role of mTOR in cancer. Cancer Cell 12: 9-22.
88. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J et al. (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11: 859-871.
89. Hao Y, Wong R, Feig LA. (2008). RalGDS couples growth factor signaling to Akt activation. Mol Cell Biol 28: 2851-2859.
90. Harrington LS, Findlay GM, Lamb RF. (2005). Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 30: 35-42.
91. Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L et al. (2004). Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease. J Biol Chem 279: 23622-23629.
92. Hawkins PT, Anderson KE, Davidson K, Stephens LR. (2006). Signalling through Class IPI 3Ks in mammalian cells. Biochem Soc Trans 34: 647-662.
93. Hiles ID, Otsu M, Volinia S, Fry MJ, Gout I, Dhand R et al. (1992). Phosphatidylinositol 3-kinase - structure and expression of the 110 kd catalytic subunit. Cell 70: 419-429.
94. Hill MM, Clark SF, Tucker DF, Birnbaum MJ, James DE, Macaulay SL. (1999). A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol Cell Biol 19: 7771-7781.
95. Hill MM, Feng J, Hemmings BA. (2002). Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr Biol 12: 1251-1255.
96. Hodgkinson CP, Sale EM, Sale GJ. (2002). Characterization of PDK2 activity against protein kinase B gamma. Biochemistry 41: 10351-10359.
97. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. (2000). Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55-57.
98. Hsiung SC, Tin A, Tamir H, Franke TF, Liu KP. (2008). Inhibition of 5-HT(1A) receptor-dependent cell survival by cAMP/protein kinase A: Role of protein phosphatase 2A and Bax. J Neurosci Res 86: 2326-2338.
99. Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S et al. (2002). The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2: 831-837.
100. Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ. (2001). Activation of Akt (Protein Kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21: 2203-2212.
101. Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ. (2004). Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res 64: 3171-3178.
102. Ingley E, Hemmings BA. (2000). PKB/Akt interacts with inosine-50 monophosphate dehydrogenase through its pleckstrin homology domain. FEBS Lett 478: 253-259.
103. Inoki K, Li Y, Zhu T, Wu J, Guan KL. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657.
104. Jahn T, Seipel P, Urschel S, Peschel C, Duyster J. (2002). Role for the adaptor protein Grb10 in the activation of Akt. Mol Cell Biol 22: 979-991.
105. Jia Y, Subramanian KK, Erneux C, Pouillon V, Hattori H, Jo H et al. (2007). Inositol 1,3,4,5-tetrakisphosphate negatively regulates phosphatidylinositol-3,4,5-trisphosphate signaling in neutrophils. Immunity 27: 453-467.
106. Jiang T, Qiu Y. (2003). Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J Biol Chem 278: 15789-15793.
107. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP. (2003). Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 100: 7569-7574.
108. Jones PF, Jakubowicz T, Hemmings BA. (1991a). Molecular cloning of a second form of rac protein kinase. Cell Reg. 2: 1001-1009.
109. Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA. (1991b). Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 88: 4171-4175.
110. Jones RG, Parsons M, Bonnard M, Chan VS, Yeh WC, Woodgett JR et al. (2000). Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med 191: 1721-1734.
111. Juhasz G, Hill JH, Yan Y, Sass M, Baehrecke EH, Backer JM et al. (2008). The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila. J Cell Biol 181: 655-666.
112. Kennedy SG, Kandel ES, Cross TK, Hay N. (1999). Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 19: 5800-5810.
113. Kihara A, Noda T, Ishihara N, Ohsumi Y. (2001). Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol 152: 519-530.
114. Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. (2001). Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901.
115. Kim AH, Sasaki T, Chao MV. (2003). JNK interacting protein 1 promotes Akt1 activation. J Biol Chem 278: 29830-29836.
116. Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B et al. (2002). Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35: 697-709.
117. Kim MS, Jeong EG, Yoo NJ, Lee SH. (2008). Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. Br J Cancer 98: 1533-1535.
118. Kim YB, Uotani S, Pierroz DD, Flier JS, Kahn BB. (2000). In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141: 2328-2339.
119. Kohn AD, Kovacina KS, Roth RA. (1995). Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 14: 4288-4295.
120. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. (1996). Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378.
121. Konishi H, Shinomura T, Kuroda S, Ono Y, Kikkawa U. (1994). Molecular cloning of rat RAC protein kinase alpha and beta and their association with protein kinase C zeta. Biochem Biophys Res Commun 205: 817-825.
122. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W et al. (2006). Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377-388.
123. Kwon T, Kwon DY, Chun J, Kim JH, Kang SS. (2000). Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1. J Biol Chem 275: 423-428.
124. Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P et al. (2006). Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci USA 103: 16906-16911.
125. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL. (1994). The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem 269: 20648-20652.
126. Li T, Tsukada S, Satterthwaite A, Havlik MH, Park H, Takatsu K et al. (1995). Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2: 451-460.
127. Li Y, Dowbenko D, Lasky LA. (2002). AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277: 11352-11361.
128. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K et al. (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153-1160.
129. Lin C, Yeh S, Lu K, Leu T, Chang W, Gean P. (2001). A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31: 841-851.
130. Liu D, Yang X, Songyang Z. (2000). Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr Biol 10: 1233-1236.
131. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R. (1997). Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI3-kinase gamma. Science 275: 394-397.
132. LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. (2008). Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat 11: 32-50.
133. Lu D, Huang J, Basu A. (2006). Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death. J Biol Chem 281: 22799-22807.
134. Lynch DK, Ellis CA, Edwards PA, Hiles ID. (1999). Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18: 8024-8032.
135. Lyons TR, Thorburn J, Ryan PW, Thorburn A, Anderson SM, Kassenbrock CK. (2007). Regulation of the Pro-apoptotic scaffolding protein POSH by Akt. J Biol Chem 282: 21987-21997.
136. Mabuchi S, Ohmichi M, Kimura A, Nishio Y, Arimoto-Ishida E, Yada-Hashimoto N et al. (2004). Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines. Endocrinology 145: 49-58.
137. Maehama T. (2007). PTEN: its deregulation and tumorigenesis. Biol Pharm Bull 30: 1624-1627.
138. Maehama T, Dixon JE. (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378.
139. Maira SM, Galetic I, Brazil DP, Kaech S, Ingley E, Thelen M et al. (2001). Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 294: 374-380.
140. Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q et al. (2003). Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model. Proc Natl Acad Sci USA 100: 7841-7846.
141. Malanga D, Scrima M, De Marco C, Fabiani F, De Rosa N, De Gisi S et al. (2008). Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle 7: 665-669.
142. Malstrom S, Tili E, Kappes D, Ceci JD, Tsichlis PN. (2001). Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc Natl Acad Sci USA 98: 14967-14972.
143. Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N. (2006). mTOR, translation initiation and cancer. Oncogene 25: 6416-6422.
144. Manning BD. (2004). Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167: 399-403.
145. Manning BD, Cantley LC. (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
146. Mayo LD, Donner DB. (2001). A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98: 11598-11603.
147. McDonald PC, Oloumi A, Mills J, Dobreva I, Maidan M, Gray V et al. (2008). Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 68: 1618-1624.
148. Meili R, Ellsworth C, Lee S, Reddy TB, Ma H, Firtel RA. (1999). Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J 18: 2092-2105.
149. Mitsuuchi Y, Johnson SW, Sonoda G, Tanno S, Golemis EA, Testa JR. (1999). Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 18: 4891-4898.
150. Nakatani K, Sakaue H, Thompson DA, Weigel RJ, Roth RA. (1999a). Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun 257: 906-910.
151. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ et al. (1999b). Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 274: 21528-21532.
152. Nawa M, Kanekura K, Hashimoto Y, Aiso S, Matsuoka M. (2008). A novel Akt/PKB-interacting protein promotes cell adhesion and inhibits familial amyotrophic lateral sclerosis-linked mutant SOD1-induced neuronal death via inhibition of PP2A-mediated dephosphorylation of Akt/PKB. Cell Signal 20: 493-505.
153. Nobukuni T, Kozma SC, Thomas G. (2007). hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling. Curr Opin Cell Biol 19: 135-141.
154. Noguchi M, Ropars V, Roumestand C, Suizu F. (2007). Protooncogene TCL1: more than just a coactivator for Akt. Faseb J 21: 2273-2284.
155. Noshita N, Lewen A, Sugawara T, Chan PH. (2002). Akt phosphorylation and neuronal survival after traumatic brain injury in mice. Neurobiol Dis 9: 294-304.
156. Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, Kashiwagi A et al. (2000). Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J Biol Chem 275: 36108-36115.
157. Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K et al. (2002). Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277: 21843-21850.
158. Ogg S, Ruvkun G. (1998). The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol Cell 2: 887-893.
159. Okubo Y, Blakesley VA, Stannard B, Gutkind S, Le Roith D. (1998). Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 273: 25961-25966.
160. Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, Varmus HE. (2002). Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1: 53-62.
161. Pap M, Cooper GM. (1998). Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 273: 19929-19932.
162. Paradis S, Ailion M, Toker A, Thomas JH, Ruvkun G. (1999). A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev 13: 1438-1452.
163. Paradis S, Ruvkun G. (1998). Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12: 2488-2498.
164. Paramio JM, Segrelles C, Ruiz S, Jorcano JL. (2001). Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol Cell Biol 21: 7449-7459.
165. Park HS, Kim MS, Huh SH, Park J, Chung J, Kang SS et al. (2002). Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J Biol Chem 277: 2573-2578.
166. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J et al. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365.
167. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J et al. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97: 3207-3212.
168. Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, Buchman AR et al. (2001). Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 15: 672-686.
169. Plas DR, Rathmell JC, Thompson CB. (2002). Homeostatic control of lymphocyte survival: potential origins and implications. Nat Immunol 3: 515-521.
170. Plas DR, Talapatra S, Edinger AL, Rathmell JC, Thompson CB. (2001). Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J Biol Chem 276: 12041-12048.
171. Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW et al. (2001). Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92: 179-212.
172. Reiling JH, Sabatini DM. (2006). Stress and mTORture signaling. Oncogene 25: 6373-6383.
173. Rickle A, Bogdanovic N, Volkman I, Winblad B, Ravid R, Cowburn RF. (2004). Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport 15: 955-959.
174. Rossig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S. (2002). Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem 277: 9684-9689.
175. Rossig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S. (2001). Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol 21: 5644-5657.
176. Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A et al. (2007). IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10: 93-99.
177. Ryder J, Su Y, Ni B. (2004). Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations. Cell Signal 16: 187-200.
178. Salinas M, Martin D, Alvarez A, Cuadrado A. (2001). Akt1/PKBalpha protects PC12 cells against the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium and reduces the levels of oxygen-free radicals. Mol Cell Neurosci 17: 67-77.
179. Salmena L, Carracedo A, Pandolfi PP. (2008). Tenets of PTEN tumor suppression. Cell 133: 403-414.
180. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
181. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E et al. (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25: 903-915.
182. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS et al. (2003). Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278: 14599-14602.
183. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF et al. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168.
184. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
185. Scanga SE, Ruel L, Binari RC, Snow B, Stambolic V, Bouchard D et al. (2000). The conserved PI30K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene 19: 3971-3977.
186. Scheid MP, Woodgett JR. (2001). PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2: 760-768.
187. Schenck A, Goto-Silva L, Collinet C, Rhinn M, Giner A, Habermann B et al. (2008). The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 133: 486-497.
188. Schu PV, Takegawa K, Fry MJ, Stack JH, Waterfield MD, Emr SD. (1993). Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science 260: 88-91.
189. Shaw RJ, Cantley LC. (2006). Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441: 424-430.
190. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J et al. (2002). PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8: 1145-1152.
191. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J et al. (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: 2537-2548.
192. Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF et al. (2002). Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 22: 2799-2809.
193. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
194. Staal SP, Hartley JW, Rowe WP. (1977). Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci USA 74: 3065-3067.
195. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y et al. (2001). Regulation of PTEN transcription by p53. Mol Cell 8: 317-325.
196. Staveley BE, Ruel L, Jin J, Stambolic V, Mastronardi FG, Heitzler P et al. (1998). Genetic analysis of protein kinase B (AKT) in Drosophila. Curr Biol 8: 599-602.
197. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB et al. (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279: 710-714.
198. Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J et al. (1997). The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89: 105-114.
199. Stephens LR, Hughes KT, Irvine RF. (1991). Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils. Nature 351: 33-39.
200. Sun L, Liu L, Yang XJ, Wu Z. (2004). Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation. J Cell Sci 117: 3021-3029.
201. Szanto I, Kahn CR. (2000). Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci USA 97: 2355-2360.
202. Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, Honea R et al. (2008). Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Invest 118: 2200-2208.
203. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. (2002). Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99: 13571-13576.
204. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. (2003). Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13: 1259-1268.
205. Toker A, Newton AC. (2000a). Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275: 8271-8274.
206. Toker A, Newton AC. (2000b). Cellular signaling: pivoting around PDK-1. Cell 103: 185-188.
207. Tokuda E, Fujita N, Oh-hara T, Sato S, Kurata A, Katayama R et al. (2007). Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res 67: 9666-9676.
208. Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T et al. (2005). Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132: 2943-2954.
209. Vandromme M, Rochat A, Meier R, Carnac G, Besser D, Hemmings BA et al. (2001). Protein kinase B beta/Akt2 plays a specific role in muscle differentiation. J Biol Chem 276: 8173-8179.
210. Verdu J, Buratovich MA, Wilder EL, Birnbaum MJ. (1999). Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat Cell Biol 1: 500-506.
211. Virbasius JV, Guilherme A, Czech MP. (1996). Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain. J Biol Chem 271: 13304-13307.
212. Wang L, Harris TE, Roth RA, Lawrence Jr JC. (2007). PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282: 20036-20044.
213. White DE, Cardiff RD, Dedhar S, Muller WJ. (2001). Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20: 7064-7072.
214. Wiznitzer M. (2004). Autism and tuberous sclerosis. J Child Neurol 19: 675-679.
215. Wurmser AE, Emr SD. (2002). Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 PtdIns 3-kinase in autophagy. J Cell Biol 158: 761-772.
216. Xu Z, Maroney AC, Dobrzanski P, Kukekov NV, Greene LA. (2001). The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol Cell Biol 21: 4713-4724.
217. Yamada E, Okada S, Saito T, Ohshima K, Sato M, Tsuchiya T et al. (2005). Akt2 phosphorylates Synip to regulate docking and fusion of GLUT4-containing vesicles. J Cell Biol 168: 921-928.
218. Yang J, Cron P, Good VM, Thompson V, Hemmings BA, Barford D. (2002a). Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat Struct Biol 9: 940-944.
219. Yang J, Cron P, Thompson V, Good VM, Hess D, Hemmings BA et al. (2002b). Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol Cell 9: 1227-1240.
220. Yano S, Tokumitsu H, Soderling TR. (1998). Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396: 584-587.
221. Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV, Cheng JQ. (2003). AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem 278: 23432-23440.
222. Yuan ZQ, Kim D, Kaneko S, Sussman M, Bokoch GM, Kruh GD et al. (2005). ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survival. J Biol Chem 280: 21483-21490.
223. Yue Y, Lypowy J, Hedhli N, Abdellatif M. (2004). Ras GTPase-activating protein binds to Akt and is required for its activation. J Biol Chem 279: 12883-12889.
224. Yun SJ, Kim EK, Tucker DF, Kim CD, Birnbaum MJ, Bae SS. (2008). Isoform-specific regulation of adipocyte differentiation by Akt/protein kinase Balpha. Biochem Biophys Res Commun 371: 138-143.
225. Zeng Z, Sarbassov dos D, Samudio IJ, Yee KW, Munsell MF, Ellen Jackson C et al (2007). Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood 109: 3509-3512.
226. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 87: 619-628.
227. Zhao AZ, Shinohara MM, Huang D, Shimizu M, Eldar-Finkelman H, Krebs EG et al. (2000). Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 275: 11348-11354.
228. Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM et al. (2003). Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3: 483-495.
229. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-252.
230. Zhou H, Li XM, Meinkoth J, Pittman RN. (2000). Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 151: 483-494.